Loan & DebtJul 1, 2026, 05:07 PM
Hims & Hers Secures $400M Receivables Purchase Facility
AI Summary
Hims & Hers Health, Inc. announced that its subsidiaries, XeCare LLC and Apostrophe Pharmacy LLC, entered into a Master Receivables Purchase Agreement (RPA) with JPMorgan Chase Bank, N.A. This agreement establishes a $400 million facility for selling eligible receivables, with an initial term of 364 days. Concurrently, the company amended its existing Revolving Credit and Guaranty Agreement to permit the RPA and incorporate a new $400 million indebtedness basket related to this facility.
Key Highlights
- Hims & Hers subsidiaries entered a Master Receivables Purchase Agreement (RPA) with JPMorgan Chase Bank, N.A.
- The RPA provides a $400,000,000 facility limit for eligible receivables.
- The RPA has an initial term of 364 days, extendable for up to one year indefinitely.
- Hims & Hers Health, Inc. guarantees the performance of its subsidiaries under the RPA.
- An amendment to the Revolving Credit and Guaranty Agreement permits the RPA and related transactions.
- The amendment adds a new basket for up to $400,000,000 in indebtedness related to the RPA.
Price Impact
More from HIMS